FORMULATION AND DEVELOPMENT OF KETOPROFEN BILAYER TABLETS
Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 4
Abstract
Aim of present research work was formulation and development of bilayer tablets of Ketoprofen to reduce the side effects of Ketoprofen and to improve the therapeutic benefits and patients’ compliance to treatment. Bi-layer tablets of Ketoprofen were prepared by direct compression technique using excipients like MCC, superdisintegrant, aspartame, colour agent were mixed properly shifted from sieve no 40. Before compression; add talc magnesium stearate mixed it well. Formulations with optimal properties have been selected to obtain bi-layer tablets of adequate quality. The in vitro dissolution study of the prepared bilayer tablets showed a controlled release of active drugs over a period of 24 hours. Keywords
Authors and Affiliations
Nagesh D R, Rakesh Kumar Jat, Ahmed Syed Mansoor
Keywords
Related Articles
- EP ID EP329097
- DOI 10.22270/ijdra.v5i4.207
- Views 107
- Downloads 0
Saxagliptin and Dapagliflozin for type 2 Diabetes mellitus: A Review
Qtern® is a fixed dose combination tablet of Saxagliptin and Dapagliflozin which is indicated for the advancement of glycaemic control in adults with type 2 diabetes mellitus (T2DM). It can be done either when medication...
Study the effects of Nipah Virus – A Review
The effect of Nipah Virus Infection is increasing day by day in today’s scenario and more number of cases are found in various countries. In India it was discovered in Sikkim, Siliguri and West Bengal. It is near borders...
TECHNOLOGY DVELOPMENT FOR POLYMER MODIFICATION TO ENHANCE SOLUBILITY OF POORLY SOLUBLE DRUG
Solubilization of poorly soluble drugs is a frequently encountered challenge in screening studies of new chemical entities as well as in formulation design and development. Solubility of some drugs is very less; these dr...
CONCEPT OF 505 (b) (2) APPLICATION: BENEFITS AND CHALLENGES
A 505(b) (2) application is a new drug application (NDA) delineated in section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act.505(b)(2) application is one that one or a lot of the investigations relied upon by the...
REGULATIONS OF ORPHAN DRUGS IN USA, EU AND INDIA-A COMPARATIVE STUDY
Orphan drugs are the drugs and natural products used in treatment, diagnosis, or prevention of rare disease. The orphan drug regulation varies in different countries. Initially a guideline (Orphan Drug Act) for orphan dr...